相似文献
1
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.
Clin Infect Dis. 2019 Mar 5;68(6):895-902. doi: 10.1093/cid/ciy874.
2
Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.
Clin Infect Dis. 2009 Apr 15;48(8):1003-32. doi: 10.1086/598513.
3
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.
Clin Infect Dis. 2019 Mar 5;68(6):e1-e47. doi: 10.1093/cid/ciy866.
4
Simulation of key interventions for seasonal influenza outbreak control at school in Changsha, China.
J Int Med Res. 2020 Jan;48(1):300060518764268. doi: 10.1177/0300060518764268. Epub 2018 Mar 23.
5
Effect of timing of amantadine chemoprophylaxis on severity of outbreaks of influenza a in adult long-term care facilities.
Clin Infect Dis. 2008 Jul 1;47(1):47-52. doi: 10.1086/588658.
6
Initiating influenza chemoprophylaxis with the first influenza case: a new institutional standard?
Clin Infect Dis. 2008 Jul 1;47(1):53-5. doi: 10.1086/588659.
7
Evaluation and management of seasonal influenza in the emergency department.
Emerg Med Clin North Am. 2012 May;30(2):271-305, viii. doi: 10.1016/j.emc.2011.10.011.
8
Control of influenza outbreaks in the nursing home: guidelines for diagnosis and management.
J Am Geriatr Soc. 1995 Jan;43(1):71-4. doi: 10.1111/j.1532-5415.1995.tb06246.x.
9
Practical management of avian influenza in humans.
Singapore Med J. 2006 Jun;47(6):471-5.
10
Seasonal influenza in primary care settings: review for primary care physicians.
WMJ. 2010 Aug;109(4):193-200.
引用本文的文献
1
Machine Learning-Based Identification of Risk Factors for ICU Mortality in 8902 Critically Ill Patients with Pandemic Viral Infection.
J Clin Med. 2025 Jul 30;14(15):5383. doi: 10.3390/jcm14155383.
2
Optimizing Antimicrobial Use in Japan: Strategies for Dosage, Combination Therapy, De-Escalation, Oral Switching, Duration, and Guideline Adherence.
Clin Pharmacol. 2025 Aug 4;17:227-233. doi: 10.2147/CPAA.S539674. eCollection 2025.
3
Influenza With and Without Oseltamivir Treatment and Neuropsychiatric Events Among Children and Adolescents.
JAMA Neurol. 2025 Aug 4. doi: 10.1001/jamaneurol.2025.1995.
4
Influenza Virus-Associated Acute Necrotizing Encephalopathy in Two Young Children: Case Report.
Reports (MDPI). 2024 Dec 22;7(4):118. doi: 10.3390/reports7040118.
5
An anti-complement homogeneous polysaccharide from ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut-lung axis and NLRP3 inflammasome activation.
Acta Pharm Sin B. 2025 Jun;15(6):3073-3091. doi: 10.1016/j.apsb.2025.04.008. Epub 2025 Apr 10.
6
A multicenter study to assess the performance of the point-of-care RT-PCR Cobas SARS-CoV-2 & Influenza A/B nucleic acid test for use on the Cobas Liat system in comparison with centralized assays across healthcare facilities in the United States.
J Clin Microbiol. 2025 Aug 13;63(8):e0145924. doi: 10.1128/jcm.01459-24. Epub 2025 Jul 2.
7
Fatal Influenza B-MRSA Coinfection in a Healthy Adolescent: Necrotizing Pneumonia, Cytokine Storm, and Multi-Organ Failure.
Children (Basel). 2025 Jun 13;12(6):766. doi: 10.3390/children12060766.
8
Does Empirical Antibiotic Use Improve Outcomes in Ventilated Patients with Pandemic Viral Infection? A Multicentre Retrospective Study.
Antibiotics (Basel). 2025 Jun 8;14(6):594. doi: 10.3390/antibiotics14060594.
9
Antiviral Prescription in Children With Influenza in US Emergency Departments: New Vaccine Surveillance Network (NVSN), 2016-2020.
Influenza Other Respir Viruses. 2025 Jun;19(6):e70124. doi: 10.1111/irv.70124.
10
Severe Influenza Patients Who Received Ventilator Management During the 2024 to 2025 Major Influenza-Endemic Season in a Tertiary Hospital in Japan.
Int Med Case Rep J. 2025 May 26;18:621-627. doi: 10.2147/IMCRJ.S519471. eCollection 2025.
本文引用的文献
1
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.
Lancet. 2018 Mar 31;391(10127):1285-1300. doi: 10.1016/S0140-6736(17)33293-2. Epub 2017 Dec 14.
2
Seasonal Incidence of Symptomatic Influenza in the United States.
Clin Infect Dis. 2018 May 2;66(10):1511-1518. doi: 10.1093/cid/cix1060.
3
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.
Lancet Respir Med. 2014 May;2(5):395-404. doi: 10.1016/S2213-2600(14)70041-4. Epub 2014 Mar 19.
4
Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients.
J Infect Dis. 2013 Feb 15;207(4):553-63. doi: 10.1093/infdis/jis726. Epub 2012 Nov 29.
5
Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.
Clin Infect Dis. 2012 May;54(10):1427-36. doi: 10.1093/cid/cis211. Epub 2012 Apr 10.
6
Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.
Ann Intern Med. 2012 Apr 3;156(7):512-24. doi: 10.7326/0003-4819-156-7-201204030-00411. Epub 2012 Feb 27.
7
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965. doi: 10.1002/14651858.CD008965.pub3.
8
Estimates of deaths associated with seasonal influenza --- United States, 1976-2007.
MMWR Morb Mortal Wkly Rep. 2010 Aug 27;59(33):1057-62.
9
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States.
JAMA. 2010 Apr 21;303(15):1517-25. doi: 10.1001/jama.2010.479.
10
Estimating influenza-associated deaths in the United States.
Am J Public Health. 2009 Oct;99 Suppl 2(Suppl 2):S225-30. doi: 10.2105/AJPH.2008.151944.
Zotero 插件